Structural insights into the activation mechanism of antimicrobial GBP1

EMBO J. 2024 Feb;43(4):615-636. doi: 10.1038/s44318-023-00023-y. Epub 2024 Jan 24.

Abstract

The dynamin-related human guanylate-binding protein 1 (GBP1) mediates host defenses against microbial pathogens. Upon GTP binding and hydrolysis, auto-inhibited GBP1 monomers dimerize and assemble into soluble and membrane-bound oligomers, which are crucial for innate immune responses. How higher-order GBP1 oligomers are built from dimers, and how assembly is coordinated with nucleotide-dependent conformational changes, has remained elusive. Here, we present cryo-electron microscopy-based structural data of soluble and membrane-bound GBP1 oligomers, which show that GBP1 assembles in an outstretched dimeric conformation. We identify a surface-exposed helix in the large GTPase domain that contributes to the oligomerization interface, and we probe its nucleotide- and dimerization-dependent movements that facilitate the formation of an antimicrobial protein coat on a gram-negative bacterial pathogen. Our results reveal a sophisticated activation mechanism for GBP1, in which nucleotide-dependent structural changes coordinate dimerization, oligomerization, and membrane binding to allow encapsulation of pathogens within an antimicrobial protein coat.

Keywords: Dynamin Superfamily; Electron Microscopy; GTPase; Guanylate-Binding Proteins; Oligomerization.

MeSH terms

  • Anti-Infective Agents*
  • Cryoelectron Microscopy
  • Dynamins / metabolism
  • GTP Phosphohydrolases* / metabolism
  • GTP-Binding Proteins / genetics
  • GTP-Binding Proteins / metabolism
  • Humans
  • Nucleotides / metabolism

Substances

  • GTP Phosphohydrolases
  • Dynamins
  • Nucleotides
  • Anti-Infective Agents
  • GBP1 protein, human
  • GTP-Binding Proteins